ScholarIQanswers from OpenAlex & ORCID
Carla J. Greenbaum
ResearcherPublications, citations & collaboration network
Carla J. Greenbaum is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Carla J. Greenbaum have?
ScholarIQindexed works
Carla J. Greenbaum has 405 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Carla J. Greenbaum have?
ScholarIQcitation count
Carla J. Greenbaum has 24,250 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Carla J. Greenbaum?
ScholarIQh-index
Carla J. Greenbaum has an h-index of 83 in OpenAlex.
What is the i10-index of Carla J. Greenbaum?
ScholarIQi10-index
Carla J. Greenbaum has an i10-index of 223 in OpenAlex.
What is the ORCID of Carla J. Greenbaum?
ScholarIQorcid
The ORCID for Carla J. Greenbaum is on the source record.
What is the OpenAlex record for Carla J. Greenbaum?
ScholarIQopenalex
The OpenAlex for Carla J. Greenbaum is on the source record.
What are the most-cited papers on Carla J. Greenbaum?
ScholarIQmost cited works
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function
Jerry P. Palmer, G. Alexander Fleming, Carla J. Greenbaum, Kevan C. Herold, Lisa D. Jansa, Hubert Kolb, John M. Lachin, Kenneth S. Polonsky, Paolo Pozzilli, Jay S. Skyler, Michael W. Steffes